Neil Gunn
Chief Executive Officer at GENETIC SIGNATURES LIMITED
Net worth: - $ as of 2024-06-29
Neil Gunn active positions
Companies | Position | Start | End |
---|---|---|---|
GENETIC SIGNATURES LIMITED | Director/Board Member | 2021-04-05 | - |
Chief Executive Officer | 2024-04-29 | - | |
NEOGENOMICS, INC. | Director/Board Member | 2023-06-25 | - |
Independent Dir/Board Member | 2023-06-25 | - | |
Alveo Technologies, Inc.
Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Director/Board Member | 2021-05-12 | - |
Independent Dir/Board Member | 2021-05-12 | - | |
Rarecells USA, Inc.
Rarecells USA, Inc. Packaged SoftwareTechnology Services Rarecells USA, Inc. is a company dedicated to early cancer detection to save lives. The company is based in New York, NY. The company believes that accurate and early cancer detection has the potential to save millions of lives. Rarecells is developing a prostate cancer test and a multi-cancer test for early cancer diagnosis. The company is currently conducting three clinical studies to evaluate the performance of their dedicated iset-based assay. The company was founded in 2011 by Patrizia Paterlini-Bréchot, who has been the CEO since 2011. | Director/Board Member | 2022-09-05 | - |
Independent Dir/Board Member | 2022-09-05 | - | |
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward. | Director/Board Member | - | - |
Career history of Neil Gunn
Former positions of Neil Gunn
Companies | Position | Start | End |
---|---|---|---|
IDbyDNA, Inc.
IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA. | Director/Board Member | 2021-05-04 | 2021-12-31 |
Chief Executive Officer | 2021-05-04 | 2021-12-31 | |
CaridianBCT, Inc.
CaridianBCT, Inc. Medical/Nursing ServicesHealth Services CaridianBCT, Inc. provides blood collection and processing services. The company specializes in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies. It was founded in 1964 and is headquartered in Lakewood, CO. | Corporate Officer/Principal | - | - |
Novartis Vaccines & Diagnostics SL | Corporate Officer/Principal | - | - |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Corporate Officer/Principal | - | - |
░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Neil Gunn
University of Portsmouth | Doctorate Degree |
Nottingham Trent University | Undergraduate Degree |
Statistics
International
United States | 8 |
United Kingdom | 3 |
Australia | 2 |
Operational
Director/Board Member | 6 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 3 |
Sectoral
Health Services | 5 |
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
GENETIC SIGNATURES LIMITED | Commercial Services |
NEOGENOMICS, INC. | Health Services |
Private companies | 8 |
---|---|
Roche Sequencing Solutions, Inc.
Roche Sequencing Solutions, Inc. Medical/Nursing ServicesHealth Services Roche Sequencing Solutions, Inc. engages in providing personalized healthcare by creating diagnostics and treatments tailored to individual genetic and disease profiles. The firm's solutions include NGS Oncology Assays, sample collection, nucleic acid extraction and library preparation. The company is headquartered in Pleasanton, CA. | Health Services |
IDbyDNA, Inc.
IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA. | Health Technology |
Alveo Technologies, Inc.
Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Health Technology |
Rarecells USA, Inc.
Rarecells USA, Inc. Packaged SoftwareTechnology Services Rarecells USA, Inc. is a company dedicated to early cancer detection to save lives. The company is based in New York, NY. The company believes that accurate and early cancer detection has the potential to save millions of lives. Rarecells is developing a prostate cancer test and a multi-cancer test for early cancer diagnosis. The company is currently conducting three clinical studies to evaluate the performance of their dedicated iset-based assay. The company was founded in 2011 by Patrizia Paterlini-Bréchot, who has been the CEO since 2011. | Technology Services |
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward. | Technology Services |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
Novartis Vaccines & Diagnostics SL | |
CaridianBCT, Inc.
CaridianBCT, Inc. Medical/Nursing ServicesHealth Services CaridianBCT, Inc. provides blood collection and processing services. The company specializes in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies. It was founded in 1964 and is headquartered in Lakewood, CO. | Health Services |
- Stock Market
- Insiders
- Neil Gunn
- Experience